Article

Risk-free polio vaccine: Recombinant expression systems for production of stabilised virus-like particles

2024-05-13

Abstract excerpt

Polioviruses have caused crippling disease in humans for centuries, prior to the successful development of vaccines in the mid-1900’s, which dramatically reduced disease prevalence. Continued use of these vaccines, however, threatens ultimate disease eradication and achievement of a polio-free world. Virus-like particles (VLPs) that lack a viral genome represent a safer potential vaccine, although they require par...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 01b07648-e1f0-59be-bd29-f8ba6db7d697
DOI: 10.1101/2024.05.13.593909

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Risk-free polio vaccine: Recombinant expression systems for production of stabilised virus-like particlesDOI 10.1101/2024.05.13.593909Read

Recombinant expression systems for production of stabilised virus-like particles as next-generation polio vaccinesSemantic proximity Read

Mammalian expression of virus-like particles as a proof of principle for next generation polio vaccinesSemantic proximity Read

Virus‑like particles as a vaccine delivery system: Myths and factsSemantic proximity Read

Advances and challenges in enveloped virus-like particle (VLP)-based vaccinesSemantic proximity Read

Virus-like particle vaccines for poliovirus types 1, 2, and 3 with enhanced thermostability expressed in insect cellsSemantic proximity Read

Increasing Type 1 Poliovirus Capsid Stability by Thermal Selection.Semantic proximity Read

Rational Engineering of Recombinant Picornavirus Capsids to Produce Safe, Protective Vaccine AntigenSemantic proximity Read

Virus‐like particles as powerful vaccination strategy against human virusesSemantic proximity Read

Platforms, advances, and technical challenges in virus-like particles-based vaccinesSemantic proximity Read

Plant-made polio type 3 stabilized VLPs—a candidate synthetic polio vaccineSemantic proximity Read

Safety and Immunogenicity of a VLP Poliovirus Vaccine: A Phase 1 TrialSemantic proximity Read

Production of antigenically stable enterovirus A71 virus-like particles in Pichia pastoris as a vaccine candidateSemantic proximity Read